Gladstone has three trustees who strategically guide the organization, ensure that Gladstone is financially stable, and promote an innovative environment so that our scientists can take big risks, think outside the box, and do what they do best: make great discoveries that will change the course of medicine.

Trustee Andy Garb

Andrew S. Garb became a Gladstone trustee in 2004.

Garb first became involved with Gladstone in 1981 when he was named legal counsel to the Gladstone trustees, and in 1995 he became trustee designate. In 2022, Garb retired from the law firm Loeb & Loeb LLP in Los Angeles, where he had been the managing partner from 1986 to 1992. At Loeb & Loeb, Garb’s clients included J. Paul Getty, Jr., the Conrad Hilton Foundation, the William Randolph Hearst Trust, and the estates of Gene Roddenberry and Frank Sinatra. As a fellow of the American College of Trust and Estate Counsel, he published and lectured extensively in the field of trust and estate law.

Garb is currently the director of the Roddenberry Foundation, a director of the Kane Educational and Research Foundation, and a director of Whittier Trust Company. He previously served as chair of the board and co-founder of Success Through the Arts Foundation, president of the board of the greater Los Angeles chapter of the Crohn’s and Colitis Foundation, and was a member of its National Grants Review Committee.

Garb earned a JD at Harvard Law School in 1967. Following a teaching/research assistantship at Yale Law School, he received his LLM from the University of Southern California Law School.

Trustee Bill Price

William S. Price, III became a Gladstone trustee in 2016, serving first on the Gladstone Foundation Board.

Price is the founder and chief executive officer at Classic Wines, LLC. He began his career as a lawyer, becoming a partner at Bain & Company before co-founding Texas Pacific Group (TPG) in 1992. TPG invested in companies as large and diverse as J.Crew, Burger King, Continental Airlines, and Petco.

Price left TPG in 2007 to pursue his passion for the wine business. He is the proprietor of Classic Wines, LLC, and Price Family Vineyards, LLC. He owns and manages several Sonoma Coast vineyards, including Durell, William James Vineyard, Alana Vineyard, One Sky Vineyard, Gap’s Crown Vineyard, and Walala Vineyard. Classic Wines has ownership interests in four additional wineries: Kistler Vineyards, Three Sticks, Head High, and Gary Farrell. An active philanthropist, Price is a board member of Common Sense Media (which rates, advocates, and educates families and schools on media and technology for kids) and Punahou School.

He completed his undergraduate studies at Stanford University then earned a JD from the Boalt Hall School of Law at UC Berkeley. He is a member of the California Bar.

Trustee Nick Simon

Nicholas J. Simon became a Gladstone trustee in 2017, serving first on the Gladstone Foundation Board.

Simon is a senior managing director in the Blackstone Life Sciences group. He joined Blackstone as part of its acquisition of Clarus in December 2018. Prior to joining Blackstone, Simon was co-founder and managing director of Clarus since its inception in 2005.

Simon has over 40 years of operating and investment experience in the healthcare sector and has led investments in biotechnology, pharmaceutical company partnerships, and medical technology. Before Clarus, he was a general partner at MPM Capital, a healthcare venture capital firm. From 1989 to 2000, he was vice president of business and corporate development at Genentech. He has served on the boards of over 30 private and public companies and is currently serving on the board of directors of Autolus Therapeutics, SFJ Pharmaceuticals, and Uniquity Bio, Inc.

Simon received a BS degree in microbiology from the University of Maryland and an MBA from Loyola University. He is also a trustee at the California Academy of Sciences.